Revenue and Net Income for GUD - Looks pretty healthy 2 meDo these look like numbers from a company that will disappear anytime soon ?
Kindly give your head a shake if you don't see a very strong company in Knight ... especially during the early years (2014-2016).
In 2014, GUD started with one million dollars and one drug (IMPAVIDO).
They spent the first 3 years bulking up financially.
It was a shell of a pharma to start but we knew over time, it would pick up speed.
10 years from now - I bet I don't even remember one of the cry-babies from here.
: )
-----------------------------------------------
Knight Therapeutics
Year Revenue Net Income
2020 199,519,000 32,085,000
2019 47,461,000 18,033,000
2018 12,500,000 24,079,000
2017 8,634,000 17,244,000
2016 5,940,000 18,560,000
2015 1,037,000 34,167,000
2014 365,000 125,859,000
Note: 2014 net income included a gain on sale of intangible asset